Arthur Rosenthal

Arthur L.
Rosenthal is the founder of Geyecue Medical Systems Ltd., founded in 2011, serving as Chief Executive Officer.
Dr. Rosenthal was the founder of EyeCue, Inc., founded in 2011, serving as Chief Executive Officer from 2011 to 2015.
Current jobs include Chairman at Arch Biosurgery, Inc. since 2011; Chairman at Interface Biologics, Inc. since 2011; Independent Director at Profound Medical Corp.
since 2018; and Professor at Boston University College of Engineering since 2010.
Former jobs include President & Chief Executive Officer at Cappella, Inc. from 2009 to 2011; Chairman & Chief Executive Officer at Labcoat Ltd. from 2005 to 2008; Executive Vice Chairman at ArraVasc Ltd. from 2011 to 2012; Independent Non-Executive Director at LivaNova USA, Inc. in 2015; Director at HydroCision, Inc.; Non-Executive Director at Ultimate Finance Holdings Ltd. from 2000 to 2010; Director at Tornado Medical Systems, Inc. from 2011 to 2012; Non-Executive Director at Renovo Ltd. from 2000 to 2010; Director at Arch Therapeutics, Inc.; Independent Director at Arch Therapeutics, Inc. from 2011 to 2015; Independent Director at LivaNova Plc from 2015 to 2022; Non-Executive Director at Arch Technologies, Inc. from 2013 to 2015; Venture Advisor at Advent International LP from 2005 to 2007; Vice President-Research & Development at C.
R.
Bard, Inc. (New Jersey); Chief Scientific Officer & Senior Vice President at Boston Scientific Corp.
from 1994 to 2005; Vice President at Davol, Inc. from 1982 to 1991; Chief Scientific Officer at Pfizer Ltd.; Vice President-Research & Development at Johnson & Johnson Medical, Inc. from 1990 to 1994.
Education includes undergraduate degree from the University of Connecticut and doctorate degree from the University of Massachusetts conferred in 1973.